Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
10.03
-0.62 (-5.82%)
At close: May 1, 2026, 4:00 PM EDT
10.07
+0.04 (0.40%)
After-hours: May 1, 2026, 7:53 PM EDT
Erasca Employees
Erasca had 103 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
103
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,209,184
Market Cap
3.12B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 0 | - |
| Dec 31, 2024 | 103 | -23 | -18.25% |
| Dec 31, 2023 | 126 | -3 | -2.33% |
| Dec 31, 2022 | 129 | 6 | 4.88% |
| Dec 31, 2021 | 123 | 21 | 20.59% |
| Jun 30, 2021 | 102 | - | - |
| Mar 31, 2021 | 102 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Beam Therapeutics | 511 |
| Alumis | 224 |
| Catalyst Pharmaceuticals | 182 |
| Edgewise Therapeutics | 146 |
| Tango Therapeutics | 137 |
| NewAmsterdam Pharma Company | 100 |
ERAS News
- 4 days ago - Erasca Stock Sinks 50% in Race for ‘Miracle' Cancer Drug. What's Behind the Historic Sell-Off. - Barrons
- 4 days ago - Erasca, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - GlobeNewsWire
- 4 days ago - Why Is Cancer Drug Developer Erasca Stock Plunging On Tuesday? - Benzinga
- 4 days ago - Erasca shares sink after patient death in early-stage cancer drug trial - Reuters
- 4 days ago - Erasca Transcript: Study result - Transcripts
- 4 days ago - Erasca Announces Positive Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors - GlobeNewsWire
- 5 days ago - Erasca to Host Conference Call and Webcast to Discuss Preliminary Phase 1 Dose Escalation Data for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 - GlobeNewsWire
- 7 weeks ago - Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results - GlobeNewsWire